Angioplasty.Org Home

Editor's Blog

Imaging and Diagnosis of Coronary Artery Disease

About Us
Donate Now to Angioplasty.Org


Email Bookmark and Share
Imaging & Diagnosis Center
Angioplasty.Org HomePatientCenterBlogDiscussion Forum
Home » Imaging Center » Imaging News » July 5, 2007

Use of CT Scans to Diagnose Peripheral Vascular Disease Subject of New Training Course Being Offered by CVCTA Education and Toshiba
Course Will Help Teach Detection of Disease Affecting Twenty Million People

July 5, 2007 -- TUSTIN, Calif. -- Strengthening its position as a leader in medical education and improved patient care, Toshiba America Medical Systems, Inc. today announced a partnership with CVCTA Education to provide a Peripheral Vascular CTA (PV-CTA) training course. This course will be the first of its kind to exceed current ACCF/AHA Level 2 requirements in the ACCF/AHA Clinical Competence Statement on Cardiac Imaging with Computed Tomography and Magnetic Resonance.

Peripheral Vascular Disease (PVD) refers to diseases of the blood vessels outside the heart and brain where there is a narrowing of vessels carrying blood to the legs, arms, stomach and/or kidneys. The most common type of PVD is Peripheral Arterial Disease (PAD) in which arteries leading to these same regions develop blockages that restrict blood circulation. PVD is common in patients predisposed to vascular diseases, such as those suffering from diabetes. According to an article in Cardiovascular Imaging, an estimated 20 million people have PVD, with three to four million people going misdiagnosed or untreated.

“PV-CTA is one of the most accurate and important non-invasive diagnostic tools available to detect PVD in patients reporting symptoms and in those who are asymptomatic,” said Doug Ryan, senior director, CT Business Unit. “Partnering with CVCTA Education to offer a comprehensive PV-CTA educational course is a step toward ensuring that PVD is properly detected and treated.”

The PV-CTA training course will be offered at CVCTA Training Centers in San Francisco, New York and Houston, several times per month with the first course starting in September. The course will use a blend of online learning and in-person training on Toshiba’s leading Aquilion CT scanners. Students will complete six hours of online didactics covering a review of anatomy and function, as well as findings and reporting. Also, in one day of hands-on workstation training, the students will be mentored on more than 25 cases of varying pathology. Students also will work on more than 75 cases via CVCTA’s proprietary MedMind CTA training software.

Created by Dr. Peter Fail from the Cardiovascular Institute of the South and Dr. Tony DeFrance from CVCTA, the PV-CTA course will provide students with more than 100 mentored cases with a wide variety of pathology, therefore exceeding the anticipated Level 2 requirements set by the ACCF and AHA. In total, the student will receive 40 hours of CME credit.

“At CVCTA Education, we are committed to continually improving patient care by offering state-of-the-art education to the medical community,” said Dr. Tony DeFrance, Medical Director of CVCTA Education. “Additionally, PV-CTA will play an important role in helping imaging centers and hospitals educate the community on the emerging information and issues regarding the overall impact of PVD and the value of this diagnostic tool.”

Additional information on the Toshiba’s PV-CTA course offered at CVCTA can be found at or

CVCTA Education is a leader in the design and delivery of innovative medical educational programs. It has centers in San Francisco, New York and Houston to deliver its courses to the medical community. In addition to the new PV-CTA offering, CVCTA trains physicians in performing, post-processing and interpreting Cardiac CT angiograms. More information about CVCTA Education can be found at

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corporation, an independent group company of Toshiba Corporation, is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corporation is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 172,000 employees worldwide and annual sales of $62 billion.

Source: Toshiba America Medical Systems

(Disclaimer: external links to news, press releases and other timely information sources are provided as a service by Angioplasty.Org, which is not responsible for the content found on any external sites. Items marked with a ($$) indicate that the external site normally restricts viewing to paid subscribers. Other sites may require free registration.

Angioplasty.Org Home •  PatientCenter

send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021